Клопидогрел в лечении сердечно-сосудистых заболеваний: современные клинические рекомендации
Аннотация
Статья посвящена определению места антиагреганта клопидогрела в лечении сердечно-сосудистых заболеваний. В ней изложены современные представления и рекомендации по этому актуальному вопросу различных групп экспертов из наиболее авторитетных международных медицинских организаций.
Список литературы
1. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persisting ST-segment elevation. Eur Heart J 2002; 23: 1809–40.
2. ACC/AHA guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002; www.acc.org.
3. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002; 106: 1893–900.
4. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003: 24; 28-66.
5. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). www.acc.org.
6. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for Percutaneous Coronary Interventions. Eur Heart J 2005; 26: 804-47.
7. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). JACC
8. ; 44: 671–719. Полный текст доступен на http://www.acc. org/clinical/guidelines/percutaneous/update/index_rev.pdf.
9. The Tack Force on the Management of Stable Angina Pectoris on the European society of Cardiology. Guidelines on the management of stable angina pectoris: executive summary. Eur Heart J 2006; 27: 1341-81. Полная версия доступна на www. escardio.org.
10. ACC/AHA Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). www.acc.org/clinical/guidelines/pad/index.pdf.
11. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). www.americanheart.org/presenter. jhtml?identifier=9181.
12. Harrington RA, Becker RC, Ezekowitz M, et al. Antithrombotic Therapy for Coronary Artery Disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 513S–48.
13. Menon V, Harrington RA, Hochman JS et al. Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 549S–75.
14. Popma JJ, Berger P Ohman E M, et al. Antithrombotic Therapy During Percutaneous Coronary Intervention. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 576S–99.
15. Stein PD, Schunemann HJ, Dalen JE, et al. Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 600S–8.
16. Clagett GP Sobel M, Jackson MR, et al. Antithrombotic Therapy in Peripheral Arterial Occlusive Disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 609S–26.
17. Albers GW, Amarenco P, Easton D, et al. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 483S–512.
18. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 457S–82.
19. Guyatt G, Schunemann HJ, Cook Det al. Applying the Grades of Recommendation for Antithrombotic and Thrombolytic Therapy. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 179S–87.
20. Patrono C, Coller B FitzGerald GA, et al. Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 234S–64.
21. Expert Consensus Document on the Use of Antiplatelet Agents. The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology. Eur Heart J 2004; 25: 166-81.
22. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation. N Engl J Med 2005; 352: 1179–89.
23. COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in
24. 852 patients with acute myocardial infarction: randomised placebo-controlled Trial. Lancet 2005; 366: 1607–21.
25. Явелов И.С. Место плавикса в медикаментозном лечении инфаркта миокарда. Фарматека 2006; 123, (8): 16-23.
26. Arntz H-R, Bossaert L, Filippatos GS. European Resuscitation Council Guidelines for Resuscitation 2005. Section 5. Initial management of acute coronary syndromes. Resuscitation 2005; 67S1: S87-96.
27. International Liaison Committee on Resuscitation. 2005 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Part 8: Stabilization of the Patient With Acute Coronary Syndromes. Circulation 2005; 112: IV-89 –110.
Рецензия
Для цитирования:
Явелов И.С. Клопидогрел в лечении сердечно-сосудистых заболеваний: современные клинические рекомендации. Кардиоваскулярная терапия и профилактика. 2006;5(5):81-86.
For citation:
Yavelov I.S. Clopidogrel in cardiovascular disease treatment: modern clinical recommendations. Cardiovascular Therapy and Prevention. 2006;5(5):81-86. (In Russ.)
Просмотров:
645
Послать статью по эл. почте 
